Trending NewsTrending NewsNASDAQ:MBOT Microbot Medical (MBOT) Stock Price, News & Analysis $3.85 +0.29 (+8.15%) Closing price 04:00 PM EasternExtended Trading$3.96 +0.11 (+2.73%) As of 07:17 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Microbot Medical Stock (NASDAQ:MBOT) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Microbot Medical alerts:Sign Up Key Stats Today's Range$3.52▼$3.9450-Day Range$2.36▼$3.8552-Week Range$0.82▼$3.94Volume5.48 million shsAverage Volume3.08 million shsMarket Capitalization$175.37 millionP/E RatioN/ADividend YieldN/APrice Target$9.00Consensus RatingBuy Company Overview Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts. Read More Microbot Medical Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks38th Percentile Overall ScoreMBOT MarketRank™: Microbot Medical scored higher than 38% of companies evaluated by MarketBeat, and ranked 719th out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingMicrobot Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageMicrobot Medical has received no research coverage in the past 90 days.Read more about Microbot Medical's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Microbot Medical are expected to grow in the coming year, from ($0.71) to ($0.52) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Microbot Medical is -6.64, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Microbot Medical is -6.64, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioMicrobot Medical has a P/B Ratio of 5.75. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted23.49% of the float of Microbot Medical has been sold short.Short Interest Ratio / Days to CoverMicrobot Medical has a short interest ratio ("days to cover") of 4.6.Change versus previous monthShort interest in Microbot Medical has recently increased by 2.26%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldMicrobot Medical does not currently pay a dividend.Dividend GrowthMicrobot Medical does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted23.49% of the float of Microbot Medical has been sold short.Short Interest Ratio / Days to CoverMicrobot Medical has a short interest ratio ("days to cover") of 4.6.Change versus previous monthShort interest in Microbot Medical has recently increased by 2.26%, indicating that investor sentiment is decreasing. News and Social Media3.0 / 5News Sentiment0.36 News SentimentMicrobot Medical has a news sentiment score of 0.36. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.54 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 14 news articles for Microbot Medical this week, compared to 2 articles on an average week.Search Interest40 people have searched for MBOT on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.MarketBeat Follows6 people have added Microbot Medical to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Microbot Medical insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 4.74% of the stock of Microbot Medical is held by insiders.Percentage Held by InstitutionsOnly 16.30% of the stock of Microbot Medical is held by institutions.Read more about Microbot Medical's insider trading history. Receive MBOT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Microbot Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address MBOT Stock News HeadlinesMicrobot Medical Inc.: Microbot Medical Granted U.S. Patent that Significantly Expands Potential Market ApplicationsAugust 21 at 2:06 AM | finanznachrichten.deMicrobot Medical granted U.S. patent that expands potential market applicationsAugust 21 at 2:06 AM | msn.comCould This Be the End of Retirement Worries?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boom. For retirees, that could mean a way to generate reliable monthly income—without the outdated 4% withdrawal rule, risky trading, or high-fee annuities. If you’re ready to stop worrying about money running out and start enjoying the freedom to cover expenses, treat loved ones, and live life on your terms, this may be exactly what you’ve been waiting for.August 22 at 2:00 AM | Investors Alley (Ad)Microbot Medical Inc. Expands LIBERTY® System IP Portfolio with New Patent Grant Amidst FDA Clearance AnticipationAugust 20 at 8:51 AM | quiverquant.comQMicrobot Medical® Granted U.S. Patent that Significantly Expands Potential Market ApplicationsAugust 20 at 8:30 AM | globenewswire.comMicrobot Medical (NASDAQ:MBOT) Stock Price Passes Above 200-Day Moving Average on Disappointing EarningsAugust 15, 2025 | americanbankingnews.comMicrobot Medical Secures Grant for Robotic System DevelopmentAugust 5, 2025 | tipranks.comMicrobot Medical® Receives Non-Dilutive Grant to Enhance Operational CapabilitiesAugust 5, 2025 | globenewswire.comSee More Headlines MBOT Stock Analysis - Frequently Asked Questions How have MBOT shares performed this year? Microbot Medical's stock was trading at $1.12 at the beginning of 2025. Since then, MBOT stock has increased by 243.8% and is now trading at $3.85. How were Microbot Medical's earnings last quarter? Microbot Medical Inc. (NASDAQ:MBOT) released its earnings results on Tuesday, August, 12th. The biotechnology company reported ($0.10) earnings per share for the quarter, missing the consensus estimate of ($0.08) by $0.02. When did Microbot Medical's stock split? Microbot Medical shares reverse split before market open on Monday, May 9th 2016.The 1-12 reverse split was announced on Friday, May 6th 2016. The number of shares owned by shareholders was adjusted after the market closes on Friday, May 6th 2016. An investor that had 100 shares of stock prior to the reverse split would have 8 shares after the split. Who are Microbot Medical's major shareholders? Microbot Medical's top institutional investors include Geode Capital Management LLC (1.09%), DNB Asset Management AS (0.53%), Lazari Capital Management Inc. (0.06%) and XTX Topco Ltd (0.05%). View institutional ownership trends. How do I buy shares of Microbot Medical? Shares of MBOT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Microbot Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Microbot Medical investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Meta Platforms (META), TransEnterix (TRXDW), Pfizer (PFE), Plug Power (PLUG) and Novavax (NVAX). Company Calendar Last Earnings8/12/2025Today8/22/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED INSTRUMENTS Sub-IndustryMedical Equipment Current SymbolNASDAQ:MBOT CIK883975 Webwww.microbotmedical.com Phone(781) 875-3605Fax781-556-5347Employees20Year Founded2010Price Target and Rating Average Price Target for Microbot Medical$9.00 High Price Target$9.00 Low Price Target$9.00 Potential Upside/Downside+135.9%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Trailing Twelve Months)($0.58) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$11.44 million Net MarginsN/A Pretax MarginN/A Return on Equity-76.27% Return on Assets-67.54% Debt Debt-to-Equity RatioN/A Current Ratio12.06 Quick Ratio12.06 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$0.67 per share Price / Book5.69Miscellaneous Outstanding Shares45,550,000Free Float43,387,000Market Cap$173.77 million OptionableOptionable Beta1.15 Social Links Elon Musk's Next MoveExplore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.Get This Free Report This page (NASDAQ:MBOT) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon Musk’s New TechnologyElon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a n...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!The “top secret” DeFi play Our #1 Coin Report reveals which protocol is building this institutional bridge...Crypto 101 Media | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredNew law could create $3.7 trillion tsunami.During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’...Brownstone Research | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredA grave, grave error.Nvidia just shattered records—hitting $4 trillion in valuation faster than any company in history. But one ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Microbot Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Microbot Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.